ISPOR CEO Rob Abbott on why HEOR must be in the room when clinical trial tech is built, and what ISPOR’s latest Top 10 HEOR Trends Report means for ClinOps.
- Clinical Research Has System Sprawl Problem
- How Clinical Trial Sites Must Adapt To The Predictive Analytics Era
- Why Patients Drop Out And How To Stop Them
- Predictive Analytics Is Reshaping How Sponsors Run Clinical Trials
- AI In Clinical Trials: Real Impact, Real Limits, What's Next
- RWD Helps Researchers Include More Patients In Lymphoma Research
- RWE Is Ready — Decision Making For Pharmaceuticals Isn't
- Building A Future-Proof, GxP-Compliant IT Infrastructure
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Running Your Trial In Your eTMF
Discover how people are part of the electronic Trial Master File trifecta and what to consider when implementing an eTMF in clinical studies.
-
How Small And Mid-Sized Biopharmaceutical Companies Can Easily Achieve Digital Innovation For Their Clinical Data
Discover how forward- thinking life science companies are defining their vision and looking for like-minded partners to execute information technology.
-
Simply Digital: Trial Technologies Help Reduce Oncology's Burden
Oncology trials are notorious for presenting participants and sites with many challenges. With the FDA having put its support behind digital tools, learn how they make oncology trials easier for everyone.
-
Crowdsource UAT: An Opportunity For Future Validation
IQVIA, a leading health information technology and clinical research company, has introduced a new validation model for eTMF patterned after approaches used within the larger tech space.
-
Collecting Trial Data From Patients In Remote Areas
Learn how mobile technology can promote trial inclusivity and diversity, and its potential to revolutionize clinical studies, making them more accessible and representative of the population.
-
10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves Them
Vendor selection in clinical trials is a pivotal process. Explore ten widespread inefficiencies in the current approach and how you can resolve them.
-
Everest Group Life Sciences EDC Products PEAK Matrix® Assessment 2024
This Everest Group report examines Medidata’s Rave EDC and its impact on the clinical development value chain of life sciences.
-
Hope In The Dark: Value In Alzheimer's Disease Research And Treatment
The May/June 2025 issue of Value & Outcomes Spotlight explores the health economics and outcomes research (HEOR) and its contribution to research and treatment of Alzheimer’s disease.
-
Defining 'Evidence Generation' Within Modern Clinical Trials
Learn how this distinctive approach centered on enabling clinical trial sponsors to gather data and generate evidence ensures the successful acquisition of diverse information.
-
How Clinical Trial Platforms Solve Disparate Data Challenges
Disparate data systems present challenges, yet clinical trial platforms provide centralized integration, standardization, advanced analytics, and strong security for an efficient solution.
RECENT NEWSLETTERS
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More
- 04.09.26 -- AI In Clinical Trials: Recruitment, eCOA Risks & Data
- 04.04.26 -- Your March Briefing: The Best In Clinical Trial Tech
- 04.02.26 -- AI Is Reshaping Clinical Trials: Here's How to Keep Up
- 03.26.26 -- AI, Telehealth & The Tools Reshaping Clinical Trials